Previous close | 66.80 |
Open | 69.25 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 69.10 - 69.60 |
52-week range | 8.40 - 69.65 |
Volume | |
Avg. volume | 114,889 |
Market cap | 2.312B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 26.61 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.